BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9328442)

  • 1. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
    Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
    Kim TW; Smart RC
    Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
    Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
    Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of skin tumor promotion by mirex: structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation.
    Moser GJ; Robinette CL; Smart RC
    Carcinogenesis; 1993 Jun; 14(6):1155-60. PubMed ID: 8508502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multihit, multistage model of chemical carcinogenesis.
    Owens DM; Wei S; Smart RC
    Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal role of enhanced cell proliferation in skin tumor promotion by mirex: a nonphorbol ester-type promoter.
    Meyer SA; Moser GJ; Monteiro-Riviere NA; Smart RC
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):265-9. PubMed ID: 8013418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
    Verma AK; Boutwell RK
    Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
    Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
    Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
    Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
    Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse.
    Birt DF; White LT; Choi B; Pelling JC
    Cancer Res; 1989 Aug; 49(15):4170-4. PubMed ID: 2472874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
    Okudaira N; Goto M; Yanobu-Takanashi R; Tamura M; An A; Abe Y; Kano S; Hagiwara S; Ishizaka Y; Okamura T
    Cancer Sci; 2011 Nov; 102(11):2000-6. PubMed ID: 21827582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.